Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and genetic determinants of nevirapine plasma trough concentration.
Giacomelli A, Rusconi S, Falvella FS, Oreni ML, Cattaneo D, Cozzi V, Renisi G, Monge E, Cheli S, Clementi E, Riva A, Galli M, Ridolfo AL. Giacomelli A, et al. Among authors: rusconi s. SAGE Open Med. 2018 Jun 5;6:2050312118780861. doi: 10.1177/2050312118780861. eCollection 2018. SAGE Open Med. 2018. PMID: 29899984 Free PMC article.
CD4 cell counts at the third month of HAART may predict clinical failure.
d'Arminio Monforte A, Testori V, Adorni F, Castelnuovo B, Bini T, Testa L, Moscatelli G, Chiesa E, Rusconi S, Abeli C, Sollima S, Musicco M, Meroni L, Galli M, Moroni M. d'Arminio Monforte A, et al. Among authors: rusconi s. AIDS. 1999 Sep 10;13(13):1669-76. doi: 10.1097/00002030-199909100-00010. AIDS. 1999. PMID: 10509568
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study).
Bonora S, Rusconi S, Calcagno A, Bracchi M, Viganò O, Cusato J, Lanzafame M, Trentalange A, Marinaro L, Siccardi M, D'Avolio A, Galli M, Di Perri G. Bonora S, et al. Among authors: rusconi s. J Antimicrob Chemother. 2015 Nov;70(11):3096-9. doi: 10.1093/jac/dkv208. Epub 2015 Jul 14. J Antimicrob Chemother. 2015. PMID: 26174719 Free article. Clinical Trial.
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study.
Baldin G, Ciccullo A, Capetti A, Rusconi S, Sterrantino G, Cossu MV, Giacomelli A, Lagi F, Latini A, Bagella P, De Luca A, Di Giambenedetto S, Madeddu G. Baldin G, et al. Among authors: rusconi s. HIV Med. 2019 Feb;20(2):164-168. doi: 10.1111/hiv.12688. Epub 2018 Nov 20. HIV Med. 2019. PMID: 30457197 Free article.
Clinical pharmacology in HIV cure research - what impact have we seen?
Giacomelli A, de Rose S, Rusconi S. Giacomelli A, et al. Among authors: rusconi s. Expert Rev Clin Pharmacol. 2019 Jan;12(1):17-29. doi: 10.1080/17512433.2019.1561272. Epub 2019 Jan 2. Expert Rev Clin Pharmacol. 2019. PMID: 30570410 Free article. Review.
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.
Giacomelli A, Fabbiani M, De Benedetto I, Nozza S, Focà E, Celesia BM, Marchetti G, Mussini C, Antinori A, d'Ettorre G, Madeddu G, Bandera A, Muscatello A, Rusconi S. Giacomelli A, et al. Among authors: rusconi s. J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27. J Med Virol. 2019. PMID: 31199538 Free article.
430 results